Cue Biopharma (CUE) Profit After Tax (QoQ) (2017 - 2025)
Cue Biopharma (CUE) Profit After Tax (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
121.28% |
| Sep 30, 2025 |
12.19% |
| Jun 30, 2025 |
30.80% |
| Mar 31, 2025 |
-29.08% |
| Dec 31, 2024 |
-9.65% |
| Sep 30, 2024 |
14.86% |
| Jun 30, 2024 |
17.62% |
| Mar 31, 2024 |
8.09% |
| Dec 31, 2023 |
-22.07% |
| Sep 30, 2023 |
16.53% |
| Jun 30, 2023 |
-0.58% |
| Mar 31, 2023 |
10.16% |
| Dec 31, 2022 |
-33.20% |
| Sep 30, 2022 |
17.06% |
| Jun 30, 2022 |
7.34% |
| Mar 31, 2022 |
-70.02% |
| Dec 31, 2021 |
35.47% |
| Sep 30, 2021 |
-26.40% |
| Jun 30, 2021 |
17.80% |
| Mar 31, 2021 |
-12.63% |
